Aurobindo Pharma gets EIR for Andhra Pradesh manufacturing facility

20 Dec 2023 Evaluate

The United States Food and Drug Administration (USFDA) has issued Establishment Inspection Report (EIR) to Aurobindo Pharma’s wholly owned subsidiary -- APL Healthcare’s Unit IV, a Formulation manufacturing facility situated at Menakuru Village, Naidupeta Mandal, Tirupati District, Andhra Pradesh. The said facility has been classified as Voluntary Action Indicated (VAI). 

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1217.45 -6.20 (-0.51%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×